Thinking of joining a study?

Register your interest

Become a volunteer?

NCT07093528 | RECRUITING | Heart Failure With Preserved Ejection Fraction

A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
Sponsor:

Mayo Clinic

Information provided by (Responsible Party):

Claire E. Raphael

Brief Summary:

To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)

Condition or disease

Heart Failure With Preserved Ejection Fraction

Coronary Microvascular Dysfunction

Intervention/treatment

Cardiovascular Magnetic Resonance (CMR)

Study Type : OBSERVATIONAL
Estimated Enrollment : 25 participants
Official Title : CMR Substudy of Coronary Sinus Reducer for the Management of Symptomatic Heart Failure With a Preserved Ejection Fraction (HFpEF) Associated With Coronary Microvascular Dysfunction (CMD)
Actual Study Start Date : 2025-10
Estimated Primary Completion Date : 2027-08
Estimated Study Completion Date : 2027-08

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Age ≥18
  • * Enrollment in main CS-reducer HFPEF study IRB# 25-002292
Exclusion Criteria
  • * Metal implants that are not suitable for MRI
  • * Inability or unwillingness of individual to give written informed consent.
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD

Location Details

NCT07093528

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Minnesota

Mayo Clinic

Rochester, Minnesota, United States, 55905